Venture
Mirador Therapeutics, Inc.
Latest Form D 2024-04-03- CIK 2017193
- State CA
- Other Health Care
- 2 Form D offerings since 2024-04-03
- Total sold
- $413M
- across 2 offerings
- Rounds
- 2
- Form D offerings since 2024-04-03
- Latest round
- $333M
- 2024-04-03 · 021-509566
- Investors
- 31
- on the latest round
Connected
named in its Form D filingsOfferings · since 2024-04-032 Form D offeringsExemptions506(b)People · Item 3Mark C. McKenna + 7 moreInvestors · dashboard1 inferred investor
Mirador Therapeutics, Inc.CIK 2017193
Round timeline
amount sold · by first filed2024-04-03 · $333M
- 2024-04-03$80M021-509562
- 2024-04-03$333M021-509566
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($333M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-509566 | First filed2024-04-03 | Latest2024-04-03 | Sought$333M | Sold$333M | Investors31 | Exemptions506(b) |
| 021-509562 | First filed2024-04-03 | Latest2024-04-03 | Sought$80M | Sold$80M | Investors3 | Exemptions506(b) |
Who backs Mirador Therapeutics, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-04-03
| Name | Relationship |
|---|---|
| Mark C. McKenna | RelationshipExecutive Officer, Director |
| Timothy K. Andrews | RelationshipExecutive Officer |
| Vika Brough | RelationshipExecutive Officer |
| Paul Berns | RelationshipDirector |
| David Bonita, M.D. | RelationshipDirector |
| Kristina Burow | RelationshipDirector |
| Scott Glenn | RelationshipDirector |
| Joseph Papa | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2024-04-03
- Latest filing
- 2024-04-03
Who backs Mirador Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗